Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yi, Jinglin
NCT05439629: Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration	Active, not recruiting	3	488	RoW	BAT5906 injection, Lucentis	Bio-Thera Solutions	Neovascular (Wet) Age-related Macular Degeneration	04/24	06/25
BAT5906-003-CR, NCT04772105: Clinical Study of the Safety and Efficacy of BAT5906 Injection	Completed	1/2	60	RoW	2.5mg of BAT5906, 4.0mg of BAT5906	Bio-Thera Solutions	Diabetic Macular Edema	11/23	11/23